ERCC3 and breast cancer: As an example, even though genomic approaches allow to identify its low and moderate penetrance variants, in vivo modeling of recurrent ERCC3 truncating mutation, which contributes to moderate risk of breast cancer in ERCC3-deficient cells, allowed to observe effects of rescuing ERCC3 repair-deficient phenotype [24].